Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37180578)

  • 1. Identifying liver metastasis-related hub genes in breast cancer and characterizing
    Chen M; Zheng W; Fang L
    PeerJ; 2023; 11():e15311. PubMed ID: 37180578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
    Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
    Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
    Durrani IA; Bhatti A; John P
    PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
    Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
    Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
    Wu Z; Wan J; Wang J; Meng X; Qian H
    Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.
    Shen C; Yin Y; Chen H; Wang R; Yin X; Cai Z; Zhang B; Chen Z; Zhou Z
    BMC Gastroenterol; 2018 Jul; 18(1):105. PubMed ID: 29973149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
    Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
    Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genes and pathways related to breast cancer metastasis in an integrated cohort.
    Wang L; Mo C; Wang L; Cheng M
    Eur J Clin Invest; 2021 Jul; 51(7):e13525. PubMed ID: 33615456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
    Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
    Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes for early detection of bone metastasis in breast cancer.
    Zhao Z; Yang H; Ji G; Su S; Fan Y; Wang M; Gu S
    Front Endocrinol (Lausanne); 2022; 13():1018639. PubMed ID: 36246872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
    Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
    J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
    [No Abstract]   [Full Text] [Related]  

  • 17. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
    Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
    PeerJ; 2021; 9():e11342. PubMed ID: 33987018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated transcriptome and network analysis identifies EZH2/CCNB1/PPARG as prognostic factors in breast cancer.
    Li Y; Chen G; Zhang K; Cao J; Zhao H; Cong Y; Qiao G
    Front Genet; 2022; 13():1117081. PubMed ID: 36712863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
    Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
    Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
    Zhang Y; Gao Y; Li Y; Zhang X; Xie H
    Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.